Replicate Bioscience Initiates a Phase 1 Trial of its Next-Generation srRNA Vaccine ...Middle East

PR Newswire - News
Replicate Bioscience Initiates a Phase 1 Trial of its Next-Generation srRNA Vaccine
SAN DIEGO, Sept. 12, 2023 /PRNewswire/ -- Replicate Bioscience, a clinical-stage company pioneering its novel self-replicating RNA (srRNA) technology to overcome the limitations of current mRNA modalities and expand use of RNA treatments to infectious disease, oncology, and autoimmune...

Hence then, the article about replicate bioscience initiates a phase 1 trial of its next generation srrna vaccine was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Replicate Bioscience Initiates a Phase 1 Trial of its Next-Generation srRNA Vaccine )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News